HFE gene mutations increase the risk of coronary heart disease in women
September 2010
Article
| Related Files |
|---|
|
(20100803_019.pdf, 0.3MB) |
|
Redirect to Publisher's version
(Publisher's version.url.txt, 43 bytes) |
he purpose of the present study is to examine HFE gene mutations in relation to newly diagnosed (incident) coronary heart disease (CHD). In a population-based follow-up study of 7,983 individuals aged 55 years and older, we compared the risk of incident CHD between HFE carriers and non-carriers, overall and stratified by sex and smoking status. HFE mutations were significantly associated with an increased risk of incident CHD in women but not in men (hazard ratio [HR] for women = 1.7, 95% confidence interval [CI] 1.2-2.4 versus HR for men = 0.9, 95% CI 0.7-1.2). This increased CHD risk associated with HFE mutations in women was statistically significant in never smokers (HR = 1.8, 95% CI 1.1-2.8) and current smokers (HR = 3.1, 95% CI 1.4-7.1), but not in former smokers (HR = 1.3, 95% CI 0.7-2.4). HFE mutations are associated with increased risk of incident CHD in women.
- mutation
- hfe mutations
- study
- women
- disease
- carrier
- smoking
- smoker
- smoking status
- non-carrier
- incident chd
- hemochromatosi
- heart disease
- level
- heart
- status
- c 282y mutation
- baseline
- chd risk
- smokers non-carriers hfe-carriers